Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Altmann

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Leukemia & Lymphoma|January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysisJan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Immunity|December 23, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signalingJayakumar Manoharan, Rajiv Rana, Georg Kuenze, et al.
Blood Advances|October 15, 2020
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AMLJayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.
Science Translational Medicine|June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemiaJayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Blood Advances|November 6, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemiaLeo Ruhnke, Marius Bill, Sven Zukunft, et al.
Human Genomics|January 24, 2026
Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON)Ayda Abolhassani, T Madhusankha Alawathurage, Axel Schmidt, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Leukemia & Lymphoma|January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysisJan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Nature Communications|March 27, 2019
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCTMaddalena Noviello, Francesco Manfredi, Eliana Ruggiero, et al.
Immunity|December 23, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signalingJayakumar Manoharan, Rajiv Rana, Georg Kuenze, et al.
Blood Advances|October 15, 2020
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AMLJayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.
Science Translational Medicine|June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemiaJayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Blood Advances|November 6, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemiaLeo Ruhnke, Marius Bill, Sven Zukunft, et al.
Human Genomics|January 24, 2026
Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON)Ayda Abolhassani, T Madhusankha Alawathurage, Axel Schmidt, et al.
Pageof 4